These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 6608081)

  • 1. [Natural and lectin-dependent cell-mediated cytotoxicity in patients with SLE and metastasizing solid tumors].
    Perl A; Rhenso GC; Láng I; Nékám K; Gergely P
    Orv Hetil; 1984 Jan; 125(3):135-7. PubMed ID: 6608081
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibodies to T cells in patients with systemic lupus erythematosus can induce antibody-dependent cell-mediated cytotoxicity against human T cells.
    Kumagai S; Steinberg AD; Green I
    J Clin Invest; 1981 Mar; 67(3):605-14. PubMed ID: 6970750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody dependent and spontaneous lymphocyte mediated cytotoxicity in normal subjects, patients with SLE, and malignancies.
    Láng I; Benczur M; Varga M; Gergely P; Petrányi G
    Acta Med Acad Sci Hung; 1977; 34(3):123-7. PubMed ID: 617926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural and antibody-dependent cellular cytotoxicity in children with systemic lupus erythematosus and juvenile dermatomyositis.
    Miller ML; Lantner R; Pachman LM
    J Rheumatol; 1983 Aug; 10(4):640-2. PubMed ID: 6620266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of natural killing with antibody dependent cell mediated cytotoxicity in patients with systemic lupus erythematosus.
    Kozlowski SH; Hirsen DJ; Jackson EJ
    J Rheumatol; 1982; 9(1):59-62. PubMed ID: 7086780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
    Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
    Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The circulating lymphocyte profiles in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathogenetic relationship.
    Wouters CH; Diegenant C; Ceuppens JL; Degreef H; Stevens EA
    Br J Dermatol; 2004 Apr; 150(4):693-700. PubMed ID: 15099365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum-induced enhancement of peripheral blood mononuclear cell mediated cytotoxicity towards human target cells in systemic lupus erythematosus.
    Wright JK; Penning CA; Ashby JC; Cunningham J; Rowell NR; Hughes P
    J Clin Lab Immunol; 1983 Jun; 11(2):81-5. PubMed ID: 6876144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antiviral immunity in families of patients with systemic lupus erythematosus and in medical personnel in contact with sick patients].
    Folomeeva OM; Nasonova VA; Alekberova ZS; Boĭchuk VV; Bulanova TD
    Ter Arkh; 1978; 50(5):34-40. PubMed ID: 307826
    [No Abstract]   [Full Text] [Related]  

  • 10. Natural killer cell activity in families of patients with systemic lupus erythematosus: demonstration of a killing defect in patients.
    Green MR; Kennell AS; Larche MJ; Seifert MH; Isenberg DA; Salaman MR
    Clin Exp Immunol; 2005 Jul; 141(1):165-73. PubMed ID: 15958083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab: a promising therapy in systemic lupus erythematosus.
    Thatayatikom A; White AJ
    Autoimmun Rev; 2006 Jan; 5(1):18-24. PubMed ID: 16338207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reconstitution of deficient T cell receptor zeta chain restores T cell signaling and augments T cell receptor/CD3-induced interleukin-2 production in patients with systemic lupus erythematosus.
    Nambiar MP; Fisher CU; Warke VG; Krishnan S; Mitchell JP; Delaney N; Tsokos GC
    Arthritis Rheum; 2003 Jul; 48(7):1948-55. PubMed ID: 12847689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-cell signaling abnormalities in human systemic lupus erythematosus.
    Nambiar MP; Krishnan S; Tsokos GC
    Methods Mol Med; 2004; 102():31-47. PubMed ID: 15286379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective natural killer (NK) and killer (K) cell function in systemic lupus erythematosus.
    Ewan PW; Barrett HM; Pusey CD
    J Clin Lab Immunol; 1983 Feb; 10(2):71-6. PubMed ID: 6842577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of cell-mediated immune responses to influenza vaccination in systemic lupus erythematosus.
    Holvast A; van Assen S; de Haan A; Huckriede A; Benne CA; Westra J; Palache A; Wilschut J; Kallenberg CG; Bijl M
    Arthritis Rheum; 2009 Aug; 60(8):2438-47. PubMed ID: 19644961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell abnormalities in systemic lupus erythematosus.
    Takeuchi T; Tsuzaka K; Abe T; Yoshimoto K; Shiraishi K; Kameda H; Amano K
    Autoimmunity; 2005 Aug; 38(5):339-46. PubMed ID: 16227148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleosomes are major T and B cell autoantigens in systemic lupus erythematosus.
    Bruns A; Bläss S; Hausdorf G; Burmester GR; Hiepe F
    Arthritis Rheum; 2000 Oct; 43(10):2307-15. PubMed ID: 11037891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in T cell receptor zeta chain mRNA of peripheral T cells from systemic lupus erythematosus patients.
    Tsuzaka K; Takeuchi T; Onoda N; Pang M; Abe T
    J Autoimmun; 1998 Oct; 11(5):381-5. PubMed ID: 9802920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus.
    Blanco P; Pitard V; Viallard JF; Taupin JL; Pellegrin JL; Moreau JF
    Arthritis Rheum; 2005 Jan; 52(1):201-11. PubMed ID: 15641052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral blood lymphocytes in SLE--hyperexpression of CD154 on T and B lymphocytes and increased number of double negative T cells.
    Devi BS; Van Noordin S; Krausz T; Davies KA
    J Autoimmun; 1998 Oct; 11(5):471-5. PubMed ID: 9802931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.